BBLG Bone Biologics Corp
2,822
$1.58
$0.07
(4.64%)
| Watchers | 2,822 |
| 52-Wk Low | $1.38 |
| 52-Wk High | $55.12 |
| Market Cap | $812,000.00 |
| Volume | 17,549.00 |
| 52-Wk High | $55.12 |
| 52-Wk Low | $1.38 |
Bone Biologics Co. (NASDAQ:BBLG) Short Interest UpdateTicker Report • about 2 months ago
Bone Biologics Co. (NASDAQ:BBLG Get Free Report) was the target of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 31,100...
Share to Feed
Bone Biologics Corporation (Bone Biologics or the Company) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously...
Bone Biologics Corporation (Bone Biologics or the Company) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its public offering of...
Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress with advancing its product candidate NB1 into human clinical testing for...
Bone Biologics files to sell common stock and warrant...
Bone Biologics Corporation (Bone Biologics or the Company) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that effective immediately Robert E...
Bone Biologics Corporation (Bone Biologics or the Company) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it has received notice from The...
Enovis (NYSE:ENOV Get Free Report) and Bone Biologics (NASDAQ:BBLG Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses...
Bone Biologics files to sell 142.4K shares for its holders...